Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1955 1
1964 3
1965 3
1966 1
1967 3
1968 5
1969 5
1971 4
1972 1
1974 2
1975 4
1976 1
1977 8
1978 2
1981 1
1982 1
1983 1
1987 1
1989 1
1990 2
1997 1
2002 1
2003 1
2004 1
2005 1
2006 2
2007 2
2010 2
2013 4
2014 1
2015 2
2017 1
2018 1
2019 2
2023 1
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean mercaptopurine (22,550 results)?
Mercaptopurine.
[No authors listed] [No authors listed] 2024 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Feb 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000074 Free Books & Documents. Review.
Combination of the histone deacetylase inhibitor valproic acid with oral hydroxyurea or 6-mercaptopurin can be safe and effective in patients with advanced acute myeloid leukaemia--a report of five cases.
Fredly H, Stapnes Bjørnsen C, Gjertsen BT, Bruserud Ø. Fredly H, et al. Hematology. 2010 Oct;15(5):338-43. doi: 10.1179/102453310X12647083620967. Hematology. 2010. PMID: 20863429
We describe five patients receiving oral treatment with low-dose oral 6-mercaptopurin and/or hydroxyurea together with ATRA+valproric acid+theophylline. ...We conclude that valproic acid+ATRA+theophylline combined with 6-mercaptopurin or hydroxyurea can be safe and …
We describe five patients receiving oral treatment with low-dose oral 6-mercaptopurin and/or hydroxyurea together with ATRA+valproric …
Management of ulcerative colitis and Crohn's disease.
Baert F, Vermeire S, Noman M, Van Assche G, D'Haens G, Rutgeerts P. Baert F, et al. Acta Clin Belg. 2004 Sep-Oct;59(5):304-14. doi: 10.1179/acb.2004.045. Acta Clin Belg. 2004. PMID: 15641402 Review.
The conventional medical treatment of IBD consists of aminosalicylates, corticosteroids, immunosuppressive drugs (azathioprine, 6-mercaptopurin, methotrexate, cyclosporin) and antibiotics. The only drugs able to modify the disease course are azathioprine, its metabolite 6- …
The conventional medical treatment of IBD consists of aminosalicylates, corticosteroids, immunosuppressive drugs (azathioprine, 6-mercapt …
The Potential of Epigallocatechin-3-gallate (EGCG) as Complementary Medicine for the Treatment of Inflammatory Bowel Disease.
Schnur S, Hans F, Dehne A, Osti J, Schneemann MO, Schneider M, Hittinger M. Schnur S, et al. Pharmaceuticals (Basel). 2023 May 14;16(5):748. doi: 10.3390/ph16050748. Pharmaceuticals (Basel). 2023. PMID: 37242530 Free PMC article.
Moreover, the full barrier integrity was maintained even after 48 h. This corresponds to the immunosuppressant 6-Mercaptopurin and the biological drug Infliximab. The EGCG treatment significantly decreased the release of the pro-inflammatory cytokines IL-6 (to 0%) and IL-8 …
Moreover, the full barrier integrity was maintained even after 48 h. This corresponds to the immunosuppressant 6-Mercaptopurin and th …
Inhibitory Effects of Quercetin and Its Human and Microbial Metabolites on Xanthine Oxidase Enzyme.
Mohos V, Pánovics A, Fliszár-Nyúl E, Schilli G, Hetényi C, Mladěnka P, Needs PW, Kroon PA, Pethő G, Poór M. Mohos V, et al. Int J Mol Sci. 2019 May 31;20(11):2681. doi: 10.3390/ijms20112681. Int J Mol Sci. 2019. PMID: 31159151 Free PMC article.
These observations highlight that some quercetin metabolites can exert similar or even a stronger inhibitory effect on xanthine oxidase than the parent compound, which may lead to the development of quercetin-drug interactions (e.g., with 6-mercaptopurin or azathioprine).. …
These observations highlight that some quercetin metabolites can exert similar or even a stronger inhibitory effect on xanthine oxidase than …
Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
Mertz Nielsen A, Theede K, Gluud LL, Kiszka-Kanowitz M. Mertz Nielsen A, et al. Scand J Gastroenterol. 2024 Mar 5:1-5. doi: 10.1080/00365521.2024.2323502. Online ahead of print. Scand J Gastroenterol. 2024. PMID: 38444060
Patients requiring optimisation initially on AZA monotherapy treatment were switched to low dose AZA in combination with allopurinol, low dose 6-mercaptopurin in combination with allopurinol, or 6-mercaptopurin treatment alone, and those treated with low dose AZA in …
Patients requiring optimisation initially on AZA monotherapy treatment were switched to low dose AZA in combination with allopurinol, low do …
Pulmonary Langerhans cell histiocytosis: a comprehensive analysis of 40 patients and literature review.
Elia D, Torre O, Cassandro R, Caminati A, Harari S. Elia D, et al. Eur J Intern Med. 2015 Jun;26(5):351-6. doi: 10.1016/j.ejim.2015.04.001. Epub 2015 Apr 17. Eur J Intern Med. 2015. PMID: 25899682 Review.
Treatments with low dose of prednisolone, vinblastine and prednisolone, or 6-mercaptopurin were reserved for patients with major pulmonary or extra-pulmonary involvement (for 11, 4, and 5 patients, respectively). ...
Treatments with low dose of prednisolone, vinblastine and prednisolone, or 6-mercaptopurin were reserved for patients with major pulm …
Maintenance chemotherapy in children with ALL exerts metronomic-like thrombospondin-1 associated anti-endothelial effect.
Andre N, Cointe S, Barlogis V, Arnaud L, Lacroix R, Pasquier E, Dignat-George F, Michel G, Sabatier F. Andre N, et al. Oncotarget. 2015 Sep 8;6(26):23008-14. doi: 10.18632/oncotarget.3984. Oncotarget. 2015. PMID: 26284583 Free PMC article.
It relies on the long-term oral administration of daily low-dose mercaptopurin and weekly low-dose methotrexate. Although it has been used in the clinic for decades, its mechanisms of action remain unclear. ...
It relies on the long-term oral administration of daily low-dose mercaptopurin and weekly low-dose methotrexate. Although it has been …
75 results